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Abstract 
The value of psychological treatment of mood disorders has been established. Family 
psychoeducation has been effective in reducing severity of symptom and prolonging the 
time to relapse among them. We investigated the efficacy of adjunctive psychoeducation 
focusing on how to cope with the expressed emotion of relatives to treatment as usual 
(TAU) to prevent relapse among patients with remitted depression. Thirty-four patients 
with depression in full or partial remission were randomised to divide patients into 
either group with psychoeducation over six sessions, each consisting of a didactic lecture 
and group problem-solving (n=19), plus TAU or TAU only (n=15). The main outcome 
was relapse. The Hamilton Rating Scale for Depression-17 (HRSD-17) was undertaken 
to evaluate the severity of depression. Eighteen patients in the intervention group and 
14 patients in the control group (TAU only) participated in this study. Time to relapse 
was significantly longer in the intervention group than in the control group, with a risk 
ratio (RR) of relapse by 9 months of 0.12. At 9 months, there was a significantly greater 
decrease in the HRSD-17 score in the intervention group than in the control group. We 
showed the efficacy of patient psychoeducation on the course and outcome of depression.  
 
Introduction      
The purpose of this study was to investigate for patients with depression the 
effectiveness of simple psychoeducation which is focussed on how to cope with relatives 
and colleagues and superiors at the workplace in a randomised controlled trial. Ethical 
approval was obtained from the ethics committees at Kochi Medical School. 
Methods 
Psychoeducational sessions 
     Group psychoeducation was conducted to the patients for six sessions which were 
held on a weekly basis. Each group gathered between two and six patients. Each session 
was about 1.5 h: the first 20–30 min were used for a lecture and were followed by group 
discussions using problem-solving techniques. 
The topics of the didactic parts included ‘Patient recognition of depression and its 
consequences’, ‘Causes and risk factors’, ‘Signs and symptoms’, ‘Drug treatment’, 
‘Side effects of antidepressants’ and ‘Course/outcome and review of the sessions’.     
Results 
     Of the 34 patients randomly allocated to the intervention and control groups, one 
patient in the intervention group and one patient in the control group withdrew their 
consent before participating the study, resulting in 32 patients who participated the 
study, with 18 in the intervention group and 14 in the control group. One patient in the 
intervention group dropped out and four patients in the control group changed hospitals. 
Follow-up data at 9 months for these five patients could not use, but we will focus on 
these 32 patients as our intention-to-treat sample, with the dropouts treated as 
censored cases as appropriate. 
     In order to control for possible confounders, we conducted Cox proportional hazard 
analysis by entering sex, age, illness duration, baseline HRSD-17 score, baseline 
antidepressant dosage and intervention; only intervention emerged as a significant 
predictor of the time to relapse (hazard ratio, HR=0.091, 95%CI: 0.01–0.87, P=0.038)  
     Nine-month outcomes were examined among the 27 patients who could be 
followed up. HRSD-17, BDI-II, CGI severity and GAF were compared between the 
intervention and control groups to evaluate the effects of psychoeducation at 9 months 
using analysis of covariance (ANCOVA) with respective baseline scores as a covariate. 
All the HRSD-17, the BDI-II, the CGI severity and the GAF scores were statistically 
significantly better in the intervention group than in the control group while controlling 
for their respective baseline scores. The CGI-improvement score was also significantly 
better in the psychoeducation group. The rate of remitted patients in the intervention 
group was 10 out of 17 (58.8%) and that in the control group was two out of 10 (20.0%), 
indicating no significant difference between the two groups (Fisher's exact test; 
P=0.110). 
Discussion 
     This study demonstrated that group psychoeducation consisting of six sessions 
was effective in treating MDDs and preventing relapses for up to 9 months of follow-up. 
Time to relapse was significantly longer in the psychoeducation group and the 9-month 
outcomes in depressive symptomatology and function were better in the intervention 
group than in the control group. These findings were not related to the drug treatment. 
There have been several studies demonstrating the effectiveness of psychoeducation on 
the course and outcome of mood disorders but our programme is distinct from the 
pre-existing ones in the following aspects. There are several factors that can explain the 
effectiveness of patient psychoeducation for major depression. One possibility is being 
associated with medication adherence. However, in our sample, adherence to the 
antidepressant treatment was not different between the intervention and control 
groups. Another possible explanation is the effect of the psychoeducation. The 
identification of the warning signs and a consequent early intervention might have been 
more effectively accomplished in the educated group. The patients in our intervention 
group may or may not have recognised more of their early signs/symptoms of relapse 
leading to successful coping with the situation. 
Limitations 
     First, the majority of our subjects suffered from mild depression and were 
middle-aged. This patient profile is very popular in outpatient treatment settings in 
Japan. However, the generalisability of our findings to other types of depression and 
other types of patients may not be taken for granted. Second, the number of patients 
was small so that we may have missed some significant effect modifiers. For example, 
there may be some variables related to the outcome other than psychoeducation. Third, 
we fell short of examining important effect modifiers in the psychoeducation. The 
mechanism of psychoeducation should be examined in more detail with assessment 
tools longitudinally measuring the knowledge and behaviour of the participants. Fourth, 
our programme consisted of narrowly defined patient psychoeducation per se plus 
problem-solving-based techniques. The patients also enjoyed long and close contact with 
mental health professionals at a high staff/patient ratio. We could not separately 
examine which of these specific and nonspecific factors were responsible for the 
observed effectiveness. Despite these weaknesses, our method of group psychoeducation, 
that is simple and easily introduced. Furthermore, it must be emphasised that it may 
well be more cost-effective both for the training and the provision of the treatment than 
individual psychotherapies. Further studies of psychoeducation in patients with major 
depression are warranted to replicate and extend the usefulness and effectiveness of 
this psychosocial treatment. 
 
